178 related articles for article (PubMed ID: 18489177)
1. Total synthesis of the Hsp90 inhibitor geldanamycin.
Qin HL; Panek JS
Org Lett; 2008 Jun; 10(12):2477-9. PubMed ID: 18489177
[TBL] [Abstract][Full Text] [Related]
2. Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin.
McErlean CS; Proisy N; Davis CJ; Boland NA; Sharp SY; Boxall K; Slawin AM; Workman P; Moody CJ
Org Biomol Chem; 2007 Feb; 5(3):531-46. PubMed ID: 17252137
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of herbimycin A.
Canova S; Bellosta V; Bigot A; Mailliet P; Mignani S; Cossy J
Org Lett; 2007 Jan; 9(1):145-8. PubMed ID: 17192106
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
5. Convergent synthesis and discovery of a natural product-inspired paralog-selective Hsp90 inhibitor.
Jeso V; Cherry L; Macklin TK; Pan SC; LoGrasso PV; Micalizio GC
Org Lett; 2011 Oct; 13(19):5108-11. PubMed ID: 21866939
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of reblastatin, autolytimycin, and non-benzoquinone analogues: potent inhibitors of heat shock protein 90.
Wrona IE; Gozman A; Taldone T; Chiosis G; Panek JS
J Org Chem; 2010 May; 75(9):2820-35. PubMed ID: 20392070
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 90: inhibitors in clinical trials.
Biamonte MA; Van de Water R; Arndt JW; Scannevin RH; Perret D; Lee WC
J Med Chem; 2010 Jan; 53(1):3-17. PubMed ID: 20055425
[No Abstract] [Full Text] [Related]
8. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
9. An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors--potential therapeutics in cancer and neurodegeneration.
Kitson RR; Moody CJ
Chem Commun (Camb); 2013 Oct; 49(76):8441-3. PubMed ID: 23770604
[TBL] [Abstract][Full Text] [Related]
10. Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90.
Kitson RR; Moody CJ
J Org Chem; 2013 Jun; 78(11):5117-41. PubMed ID: 23496136
[TBL] [Abstract][Full Text] [Related]
11. The missing C-17 O-methyltransferase in geldanamycin biosynthesis.
Yin M; Lu T; Zhao LX; Chen Y; Huang SX; Lohman JR; Xu LH; Jiang CL; Shen B
Org Lett; 2011 Jul; 13(14):3726-9. PubMed ID: 21682254
[TBL] [Abstract][Full Text] [Related]
12. Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.
Franke J; Eichner S; Zeilinger C; Kirschning A
Nat Prod Rep; 2013 Oct; 30(10):1299-323. PubMed ID: 23934201
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.
Li YP; Chen JJ; Shen JJ; Cui J; Wu LZ; Wang Z; Li ZR
Cancer Chemother Pharmacol; 2015 Apr; 75(4):773-82. PubMed ID: 25681003
[TBL] [Abstract][Full Text] [Related]
14. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90.
Kitson RR; Chang CH; Xiong R; Williams HE; Davis AL; Lewis W; Dehn DL; Siegel D; Roe SM; Prodromou C; Ross D; Moody CJ
Nat Chem; 2013 Apr; 5(4):307-14. PubMed ID: 23511419
[TBL] [Abstract][Full Text] [Related]
16. Geldanamycin-inspired compounds induce direct trans-differentiation of human mesenchymal stem cells to neurons.
Jogula S; Soorneedi AR; Gaddam J; Chamakuri S; Deora GS; Indarapu RK; Ramgopal MK; Dravida S; Arya P
Eur J Med Chem; 2017 Jul; 135():110-116. PubMed ID: 28441579
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Xu H; Wu Y; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Oct; 85():359-70. PubMed ID: 25105924
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo Evaluation of 17-phenylpropylamine/phenoxyethylamine- 17-demethoxygeldanamycins as Potent Hsp90 Inhibitors.
Li Z; Jia L; Xu H; Lu C; Shena Y
Med Chem; 2015; 11(5):482-8. PubMed ID: 25537129
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of macbecin as an Hsp90 inhibitor.
Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
[TBL] [Abstract][Full Text] [Related]
20. New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus.
Wu CZ; Moon AN; Jang JH; Lee D; Kang SY; Park JT; Ahn JS; Hwang BY; Kim YH; Lee HS; Hong YS
J Antibiot (Tokyo); 2011 Jun; 64(6):461-3. PubMed ID: 21448187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
